Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vera Therapeutics, Inc. - Class A Common Stock
(NQ:
VERA
)
42.66
-0.25 (-0.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vera Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
↗
November 10, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Recap: Vera Therapeutics Q3 Earnings
↗
November 09, 2023
Via
Benzinga
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results
November 09, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023
November 04, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Recap: Vera Therapeutics Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Vera Therapeutics Scheduled to Present at November Investor Conferences
October 30, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting
October 13, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Why Shares of Vera Therapeutics Jumped Tuesday
↗
September 26, 2023
The stock bounced back Tuesday from a three-month low it hit on Monday.
Via
The Motley Fool
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 26, 2023
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...
Via
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
↗
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Vera Therapeutics Scheduled to Present at September Investor Conferences
August 31, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
↗
August 16, 2023
Via
Benzinga
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
August 10, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Around $8.5M Bet On Eagle Bulk Shipping? Check Out These 4 Stocks Insiders Are Buying
↗
June 23, 2023
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Why Shares of Vera Therapeutics Jumped Tuesday
↗
June 20, 2023
The company announced early phase 2 trials information regarding its lead therapy.
Via
The Motley Fool
Vera Therapeutics Stock Is Trading Higher Today - Here's Why
↗
June 20, 2023
On Saturday, Vera Therapeutics Inc (NASDAQ: VERA) announced that the Phase 2b ORIGIN trial of atacicept for the treatment of IgA nephropathy (IgAN) met its primary and key secondary endpoints, with...
Via
Benzinga
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday
↗
June 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
2 Surging Healthcare Stocks With More Fuel in the Tank
↗
June 20, 2023
These stocks climbed 74% and 78% over the past month and there could be more gains ahead.
Via
The Motley Fool
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress
June 17, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Host Presentation of Week 36 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN
June 15, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 15, 2023
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 14, 2023
Via
Benzinga
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 12, 2023
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.
Via
Benzinga
Why Shares of Vera Therapeutics Are Soaring Monday
↗
June 12, 2023
The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.
Via
The Motley Fool
US Stocks Open Higher; Nasdaq Rises Over 50 Points
↗
June 12, 2023
U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 12, 2023
Via
Benzinga
7 Stocks That Wall Street Analysts Are Loving in June
↗
June 11, 2023
Sometimes, it’s better to get your ideas from the experts. Thus, if you lack time, these top analyst recommend stocks could be enticing.
Via
InvestorPlace
Vera Therapeutics to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
June 08, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Initiates Pivotal Phase 3 (ORIGIN 3) Clinical Trial of Atacicept for the Treatment of IgA Nephropathy (IgAN)
June 07, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Provides Business Update and Reports First Quarter Financial Results
May 11, 2023
From
Vera Therapeutics
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
